Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia

Stroke

Volumn 31, Issue 9, 2000, Pages 2212-2217

  Schabitz, W R ^a   Sommer, C ^a   Zoder, W ^a   Kiessling, M ^a   Schwaninger, M ^a   Schwab, S ^a   Finklestein, S P ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Brain derived neurotrophic factor; Middle cerebral artery occlusion; Proteins; Rats

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; PROTEIN BAX; PROTEIN BCL 2; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG ACTIVITY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 0033811469     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.9.2212     Document Type: Article

References (0)